Cargando…
A comparison of current serum biomarkers as diagnostic indicators of mitochondrial diseases
OBJECTIVE: To directly compare the diagnostic utility of growth differentiation factor–15 (GDF-15) with our previous fibroblast growth factor–21 (FGF-21) findings in the same adult mitochondrial disease cohort. METHODS: Serum GDF-15 levels were measured using a quantitative ELISA. Statistical analys...
Autores principales: | Davis, Ryan L., Liang, Christina, Sue, Carolyn M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887120/ https://www.ncbi.nlm.nih.gov/pubmed/27164684 http://dx.doi.org/10.1212/WNL.0000000000002705 |
Ejemplares similares
-
Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives
por: Park, Jin-Sung, et al.
Publicado: (2018) -
Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
por: Reinson, Tina, et al.
Publicado: (2023) -
Serum Ferritin as a Diagnostic Biomarker for Kawasaki Disease
por: Kim, Sung Hoon, et al.
Publicado: (2021) -
Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
por: Davis, Ryan L., et al.
Publicado: (2022) -
Serum biomarkers in primary mitochondrial disorders
por: Varhaug, Kristin N, et al.
Publicado: (2021)